Q2 EPS Estimates for Nuvectis Pharma Boosted by Roth Capital
Nuvectis Pharma, Inc. (NASDAQ:NVCT – Free Report) – Analysts at Roth Capital upped their Q2 2025 earnings per share estimates for shares of Nuvectis Pharma in a research note issued to investors on Tuesday, May 6th. Roth Capital analyst J. Aschoff now anticipates that the company will post earnings of ($0.21) per share for the […]
Nuvectis Pharma, Inc. (NASDAQ:NVCT – Free Report) – Analysts at Roth Capital upped their Q2 2025 earnings per share estimates for shares of Nuvectis Pharma in a research note issued to investors on Tuesday, May 6th. Roth Capital analyst J. Aschoff now anticipates that the company will post earnings of ($0.21) per share for the […]
